Victor de Lédinghen
945 works · 50,594 citations · h-index 109
Top works
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
- Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
- Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
- Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases
- Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
- Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
- Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients
- Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B
- Determination of reliability criteria for liver stiffness evaluation by transient elastography
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages
- Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients
- Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores